Low-dose aspirin significantly lowers cardiovascular disease risk but increases the risk of bleeding, according to a review published in the British Journal of Clinical Pharmacology.
Jun 3, 2020
0
3
(HealthDay)—Diabetes screening practices vary widely and are only partially explained by patient, provider, and clinic factors, according to a study published online March 5 in Diabetes Care.
Mar 18, 2020
0
2
The most recent guidelines for primary prevention recommend aspirin use for individuals ages 40 to 70 years who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at increasingly ...
Feb 17, 2020
0
5
When the state of Michigan expanded its Medicaid program to provide health coverage to more low-income residents, its leaders built special features into the plan, different from most states. They wanted to encourage enrollees ...
Dec 9, 2019
0
10
A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use. Researchers concluded that aspirin ...
Dec 9, 2019
0
81
The benefits of statins for people without heart disease (known as primary prevention) is small and uncertain and there are potential harms, say researchers in The BMJ today.
Oct 16, 2019
0
193
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) finds that the current evidence is insufficient to recommend primary care-based interventions to prevent illicit drug use in children, adolescents, and young ...
Oct 2, 2019
0
0
Implantable cardioverter-defibrillator (ICD) use is associated with reduced short- and long-term mortality in patients with heart failure, according to late breaking research presented in a Hot Line Session today at ESC Congress ...
Sep 3, 2019
0
1
Nearly one-third of patients with an implantable cardioverter defibrillator (ICD) resume driving despite it being medically contraindicated—a practice that is dangerous for themselves and others, and is illegal in some ...
Sep 3, 2019
0
2
Age-adjusted mortality rates (AAMRs) for cardiometabolic diseases are continuing to decline but at a slower rate, according to a research letter published online Aug. 27 in the Journal of the American Medical Association.
Aug 28, 2019
0
0
